All 1 tracked stories fall under one category: earnings. TELA Bio is most often covered alongside Intrusion Inc., which appears in 1 of these 1 story. Their average consequence score of 5 runs below the beat's 6.2 for that window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about TELA Bio
All 1 tracked stories fall under one category: earnings. TELA Bio is most often covered alongside Intrusion Inc., which appears in 1 of these 1 story. Their average consequence score of 5 runs below the beat's 6.2 for that window. Source depth averages 3 original sources per story, versus 2.4 across the same-window beat baseline. We currently track 1 Finance story that mention TELA Bio, all published on March 24, 2026.
Stories tracked
1
Sources per story
3
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 119 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering TELA Bio. Shared-story counts are live from our verified record — not editorial picks.
Reed’s, Intrusion Inc., and TELA Bio released Q4 and full-year 2025 results, highlighting a period of transition for several micro-cap players. While Reed’s announced a significant leadership change, TELA Bio faces regulatory challenges following a recent delisting notice.
TELA Bio is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.